Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Pharmaceuticals (Basel). 2022 Oct 26;15(11):1321. doi: 10.3390/ph15111321.
Pharmaceuticals (Basel). 2022.
PMID: 36355493
Free PMC article.
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.
Nawar N, Bukhari S, Adile AA, Suk Y, Manaswiyoungkul P, Toutah K, Olaoye OO, Raouf YS, Sedighi A, Garcha HK, Hassan MM, Gwynne W, Israelian J, Radu TB, Geletu M, Abdeldayem A, Gawel JM, Cabral AD, Venugopal C, de Araujo ED, Singh SK, Gunning PT.
Nawar N, et al. Among authors: garcha hk.
J Med Chem. 2022 Feb 24;65(4):3193-3217. doi: 10.1021/acs.jmedchem.1c01585. Epub 2022 Feb 4.
J Med Chem. 2022.
PMID: 35119267
Item in Clipboard
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches.
Nawar N, Garcha HK, Sedighi A, de Araujo ED, Gunning PT.
Nawar N, et al. Among authors: garcha hk.
Methods Mol Biol. 2023;2589:157-177. doi: 10.1007/978-1-0716-2788-4_11.
Methods Mol Biol. 2023.
PMID: 36255624
Item in Clipboard
Cite
Cite